News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Robert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD

Articles by Robert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD

Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)

ByRobert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD,Brenda Motheral, PhD,Doug Mager, BS

April 1st 2004

Latest Updated Articles

Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)
Published: April 1st 2004 | Updated:

Trending on AJMC

Trump Strikes 9 New Pricing Agreements as Drugmakers Navigate Tariff, Regulatory Pressure

Fuzuloparib Monotherapy Improves PFS in Advanced Ovarian Cancer, but Adding Apatinib Offers No Additional Benefit

House Republicans Block Vote on ACA Subsidy Extension

Top 5 Inflammation Articles of 2025

Top 5 Myasthenia Gravis Content of 2025

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.